This observational study shows significant changes in hematocrit levels and platelet counts in dengue hemorrhagic fever patients, indicating potential complications.
Key Points
Significant differences in hematocrit levels were found between days 4 and 6 of fever in DHF patients.
Statistical analysis yielded a p-value of 0.002 for hematocrit levels and 0.000 for platelet counts.
Descriptive quantitative design included 35 DHF patients monitored for hematocrit and platelet changes across the critical fever phase.
Findings suggest that monitoring these parameters is crucial for managing potential complications in DHF.